Generic injectable drugs refer to sterile solutions (including emulsions and suspensions) made of drugs for injection into the body, and sterile powders or concentrated solutions that are prepared into solutions or suspensions before use.
The injection is fast and reliable, not affected by pH, enzymes, food, etc., has no first-pass effect, and can play a systemic or local positioning effect. It is suitable for patients who are not suitable for oral medicine and patients who cannot be taken orally. However, the development and production process of injections is complicated and safe. The body has poor adaptability and high cost.
This report aims to provide a comprehensive presentation of the global market for Generic Injectable Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Generic Injectable Drugs. This report contains market size and forecasts of Generic Injectable Drugs in global, including the following market information:
Global Generic Injectable Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Generic Injectable Drugs market was valued at US$ 31500 million in 2022 and is projected to reach US$ 39670 million by 2029, at a CAGR of 3.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In the segment of generic sterile injectable drugs, the Hospira (Pfizer Inc.) is the largest player, and Fresenius Kabi is the second. Top two players hold a share about 27% in 2019. The US market is dominated by two players like Hospira (Pfizer Inc.), Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, Dr. Reddy?s Laboratories Ltd, Grifols, Nichi-Iko Group (Sagent), Teva Pharmaceutical, Auromedics, Sanofi, Gland Pharma and Endo International PLC.
We surveyed the Generic Injectable Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Generic Injectable Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Generic Injectable Drugs Market Segment Percentages, by Type, 2022 (%)
Small Molecule
Large Molecule
Global Generic Injectable Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Generic Injectable Drugs Market Segment Percentages, by Application, 2022 (%)
Oncology
Anesthesia
Anti-Infectives
Parenteral Nutrition
Cardiovascular Diseases
Global Generic Injectable Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Generic Injectable Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Generic Injectable Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Generic Injectable Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hospira (Pfizer Inc.)
Fresenius Kabi
Sandoz (Novartis)
Hikma Pharmaceuticals PLC
Dr. Reddy?s Laboratories Ltd
Grifols
Nichi-Iko Group (Sagent)
Teva Pharmaceutical
Auromedics
Sanofi
Gland Pharma
Endo International PLC
Outline of Major Chapters:
Chapter 1: Introduces the definition of Generic Injectable Drugs, market overview.
Chapter 2: Global Generic Injectable Drugs market size in revenue.
Chapter 3: Detailed analysis of Generic Injectable Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Generic Injectable Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Generic Injectable Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Generic Injectable Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Generic Injectable Drugs Overall Market Size
2.1 Global Generic Injectable Drugs Market Size: 2022 VS 2029
2.2 Global Generic Injectable Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Generic Injectable Drugs Players in Global Market
3.2 Top Global Generic Injectable Drugs Companies Ranked by Revenue
3.3 Global Generic Injectable Drugs Revenue by Companies
3.4 Top 3 and Top 5 Generic Injectable Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Generic Injectable Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Generic Injectable Drugs Players in Global Market
3.6.1 List of Global Tier 1 Generic Injectable Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Generic Injectable Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Generic Injectable Drugs Market Size Markets, 2022 & 2029
4.1.2 Small Molecule
4.1.3 Large Molecule
4.2 By Type - Global Generic Injectable Drugs Revenue & Forecasts
4.2.1 By Type - Global Generic Injectable Drugs Revenue, 2018-2023
4.2.2 By Type - Global Generic Injectable Drugs Revenue, 2024-2029
4.2.3 By Type - Global Generic Injectable Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Generic Injectable Drugs Market Size, 2022 & 2029
5.1.2 Oncology
5.1.3 Anesthesia
5.1.4 Anti-Infectives
5.1.5 Parenteral Nutrition
5.1.6 Cardiovascular Diseases
5.2 By Application - Global Generic Injectable Drugs Revenue & Forecasts
5.2.1 By Application - Global Generic Injectable Drugs Revenue, 2018-2023
5.2.2 By Application - Global Generic Injectable Drugs Revenue, 2024-2029
5.2.3 By Application - Global Generic Injectable Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Generic Injectable Drugs Market Size, 2022 & 2029
6.2 By Region - Global Generic Injectable Drugs Revenue & Forecasts
6.2.1 By Region - Global Generic Injectable Drugs Revenue, 2018-2023
6.2.2 By Region - Global Generic Injectable Drugs Revenue, 2024-2029
6.2.3 By Region - Global Generic Injectable Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Generic Injectable Drugs Revenue, 2018-2029
6.3.2 US Generic Injectable Drugs Market Size, 2018-2029
6.3.3 Canada Generic Injectable Drugs Market Size, 2018-2029
6.3.4 Mexico Generic Injectable Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Generic Injectable Drugs Revenue, 2018-2029
6.4.2 Germany Generic Injectable Drugs Market Size, 2018-2029
6.4.3 France Generic Injectable Drugs Market Size, 2018-2029
6.4.4 U.K. Generic Injectable Drugs Market Size, 2018-2029
6.4.5 Italy Generic Injectable Drugs Market Size, 2018-2029
6.4.6 Russia Generic Injectable Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Generic Injectable Drugs Market Size, 2018-2029
6.4.8 Benelux Generic Injectable Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Generic Injectable Drugs Revenue, 2018-2029
6.5.2 China Generic Injectable Drugs Market Size, 2018-2029
6.5.3 Japan Generic Injectable Drugs Market Size, 2018-2029
6.5.4 South Korea Generic Injectable Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Generic Injectable Drugs Market Size, 2018-2029
6.5.6 India Generic Injectable Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Generic Injectable Drugs Revenue, 2018-2029
6.6.2 Brazil Generic Injectable Drugs Market Size, 2018-2029
6.6.3 Argentina Generic Injectable Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Generic Injectable Drugs Revenue, 2018-2029
6.7.2 Turkey Generic Injectable Drugs Market Size, 2018-2029
6.7.3 Israel Generic Injectable Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Generic Injectable Drugs Market Size, 2018-2029
6.7.5 UAE Generic Injectable Drugs Market Size, 2018-2029
7 Generic Injectable Drugs Companies Profiles
7.1 Hospira (Pfizer Inc.)
7.1.1 Hospira (Pfizer Inc.) Company Summary
7.1.2 Hospira (Pfizer Inc.) Business Overview
7.1.3 Hospira (Pfizer Inc.) Generic Injectable Drugs Major Product Offerings
7.1.4 Hospira (Pfizer Inc.) Generic Injectable Drugs Revenue in Global Market (2018-2023)
7.1.5 Hospira (Pfizer Inc.) Key News & Latest Developments
7.2 Fresenius Kabi
7.2.1 Fresenius Kabi Company Summary
7.2.2 Fresenius Kabi Business Overview
7.2.3 Fresenius Kabi Generic Injectable Drugs Major Product Offerings
7.2.4 Fresenius Kabi Generic Injectable Drugs Revenue in Global Market (2018-2023)
7.2.5 Fresenius Kabi Key News & Latest Developments
7.3 Sandoz (Novartis)
7.3.1 Sandoz (Novartis) Company Summary
7.3.2 Sandoz (Novartis) Business Overview
7.3.3 Sandoz (Novartis) Generic Injectable Drugs Major Product Offerings
7.3.4 Sandoz (Novartis) Generic Injectable Drugs Revenue in Global Market (2018-2023)
7.3.5 Sandoz (Novartis) Key News & Latest Developments
7.4 Hikma Pharmaceuticals PLC
7.4.1 Hikma Pharmaceuticals PLC Company Summary
7.4.2 Hikma Pharmaceuticals PLC Business Overview
7.4.3 Hikma Pharmaceuticals PLC Generic Injectable Drugs Major Product Offerings
7.4.4 Hikma Pharmaceuticals PLC Generic Injectable Drugs Revenue in Global Market (2018-2023)
7.4.5 Hikma Pharmaceuticals PLC Key News & Latest Developments
7.5 Dr. Reddy?s Laboratories Ltd
7.5.1 Dr. Reddy?s Laboratories Ltd Company Summary
7.5.2 Dr. Reddy?s Laboratories Ltd Business Overview
7.5.3 Dr. Reddy?s Laboratories Ltd Generic Injectable Drugs Major Product Offerings
7.5.4 Dr. Reddy?s Laboratories Ltd Generic Injectable Drugs Revenue in Global Market (2018-2023)
7.5.5 Dr. Reddy?s Laboratories Ltd Key News & Latest Developments
7.6 Grifols
7.6.1 Grifols Company Summary
7.6.2 Grifols Business Overview
7.6.3 Grifols Generic Injectable Drugs Major Product Offerings
7.6.4 Grifols Generic Injectable Drugs Revenue in Global Market (2018-2023)
7.6.5 Grifols Key News & Latest Developments
7.7 Nichi-Iko Group (Sagent)
7.7.1 Nichi-Iko Group (Sagent) Company Summary
7.7.2 Nichi-Iko Group (Sagent) Business Overview
7.7.3 Nichi-Iko Group (Sagent) Generic Injectable Drugs Major Product Offerings
7.7.4 Nichi-Iko Group (Sagent) Generic Injectable Drugs Revenue in Global Market (2018-2023)
7.7.5 Nichi-Iko Group (Sagent) Key News & Latest Developments
7.8 Teva Pharmaceutical
7.8.1 Teva Pharmaceutical Company Summary
7.8.2 Teva Pharmaceutical Business Overview
7.8.3 Teva Pharmaceutical Generic Injectable Drugs Major Product Offerings
7.8.4 Teva Pharmaceutical Generic Injectable Drugs Revenue in Global Market (2018-2023)
7.8.5 Teva Pharmaceutical Key News & Latest Developments
7.9 Auromedics
7.9.1 Auromedics Company Summary
7.9.2 Auromedics Business Overview
7.9.3 Auromedics Generic Injectable Drugs Major Product Offerings
7.9.4 Auromedics Generic Injectable Drugs Revenue in Global Market (2018-2023)
7.9.5 Auromedics Key News & Latest Developments
7.10 Sanofi
7.10.1 Sanofi Company Summary
7.10.2 Sanofi Business Overview
7.10.3 Sanofi Generic Injectable Drugs Major Product Offerings
7.10.4 Sanofi Generic Injectable Drugs Revenue in Global Market (2018-2023)
7.10.5 Sanofi Key News & Latest Developments
7.11 Gland Pharma
7.11.1 Gland Pharma Company Summary
7.11.2 Gland Pharma Business Overview
7.11.3 Gland Pharma Generic Injectable Drugs Major Product Offerings
7.11.4 Gland Pharma Generic Injectable Drugs Revenue in Global Market (2018-2023)
7.11.5 Gland Pharma Key News & Latest Developments
7.12 Endo International PLC
7.12.1 Endo International PLC Company Summary
7.12.2 Endo International PLC Business Overview
7.12.3 Endo International PLC Generic Injectable Drugs Major Product Offerings
7.12.4 Endo International PLC Generic Injectable Drugs Revenue in Global Market (2018-2023)
7.12.5 Endo International PLC Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Generic Injectable Drugs Market Opportunities & Trends in Global Market
Table 2. Generic Injectable Drugs Market Drivers in Global Market
Table 3. Generic Injectable Drugs Market Restraints in Global Market
Table 4. Key Players of Generic Injectable Drugs in Global Market
Table 5. Top Generic Injectable Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Generic Injectable Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Generic Injectable Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Generic Injectable Drugs Product Type
Table 9. List of Global Tier 1 Generic Injectable Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Generic Injectable Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Generic Injectable Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Generic Injectable Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Generic Injectable Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Generic Injectable Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Generic Injectable Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Generic Injectable Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Generic Injectable Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Generic Injectable Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Generic Injectable Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Generic Injectable Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Generic Injectable Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Generic Injectable Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Generic Injectable Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Generic Injectable Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Generic Injectable Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Generic Injectable Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Generic Injectable Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Generic Injectable Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Generic Injectable Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Hospira (Pfizer Inc.) Company Summary
Table 31. Hospira (Pfizer Inc.) Generic Injectable Drugs Product Offerings
Table 32. Hospira (Pfizer Inc.) Generic Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Hospira (Pfizer Inc.) Key News & Latest Developments
Table 34. Fresenius Kabi Company Summary
Table 35. Fresenius Kabi Generic Injectable Drugs Product Offerings
Table 36. Fresenius Kabi Generic Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Fresenius Kabi Key News & Latest Developments
Table 38. Sandoz (Novartis) Company Summary
Table 39. Sandoz (Novartis) Generic Injectable Drugs Product Offerings
Table 40. Sandoz (Novartis) Generic Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Sandoz (Novartis) Key News & Latest Developments
Table 42. Hikma Pharmaceuticals PLC Company Summary
Table 43. Hikma Pharmaceuticals PLC Generic Injectable Drugs Product Offerings
Table 44. Hikma Pharmaceuticals PLC Generic Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Hikma Pharmaceuticals PLC Key News & Latest Developments
Table 46. Dr. Reddy?s Laboratories Ltd Company Summary
Table 47. Dr. Reddy?s Laboratories Ltd Generic Injectable Drugs Product Offerings
Table 48. Dr. Reddy?s Laboratories Ltd Generic Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Dr. Reddy?s Laboratories Ltd Key News & Latest Developments
Table 50. Grifols Company Summary
Table 51. Grifols Generic Injectable Drugs Product Offerings
Table 52. Grifols Generic Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Grifols Key News & Latest Developments
Table 54. Nichi-Iko Group (Sagent) Company Summary
Table 55. Nichi-Iko Group (Sagent) Generic Injectable Drugs Product Offerings
Table 56. Nichi-Iko Group (Sagent) Generic Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Nichi-Iko Group (Sagent) Key News & Latest Developments
Table 58. Teva Pharmaceutical Company Summary
Table 59. Teva Pharmaceutical Generic Injectable Drugs Product Offerings
Table 60. Teva Pharmaceutical Generic Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Teva Pharmaceutical Key News & Latest Developments
Table 62. Auromedics Company Summary
Table 63. Auromedics Generic Injectable Drugs Product Offerings
Table 64. Auromedics Generic Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Auromedics Key News & Latest Developments
Table 66. Sanofi Company Summary
Table 67. Sanofi Generic Injectable Drugs Product Offerings
Table 68. Sanofi Generic Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Sanofi Key News & Latest Developments
Table 70. Gland Pharma Company Summary
Table 71. Gland Pharma Generic Injectable Drugs Product Offerings
Table 72. Gland Pharma Generic Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Gland Pharma Key News & Latest Developments
Table 74. Endo International PLC Company Summary
Table 75. Endo International PLC Generic Injectable Drugs Product Offerings
Table 76. Endo International PLC Generic Injectable Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Endo International PLC Key News & Latest Developments
List of Figures
Figure 1. Generic Injectable Drugs Segment by Type in 2022
Figure 2. Generic Injectable Drugs Segment by Application in 2022
Figure 3. Global Generic Injectable Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Generic Injectable Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Generic Injectable Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Generic Injectable Drugs Revenue in 2022
Figure 8. By Type - Global Generic Injectable Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Generic Injectable Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Generic Injectable Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Generic Injectable Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Generic Injectable Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Generic Injectable Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Generic Injectable Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Generic Injectable Drugs Revenue Market Share, 2018-2029
Figure 16. US Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Generic Injectable Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Generic Injectable Drugs Revenue Market Share, 2018-2029
Figure 28. China Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Generic Injectable Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Generic Injectable Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Generic Injectable Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Hospira (Pfizer Inc.) Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Fresenius Kabi Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Sandoz (Novartis) Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Hikma Pharmaceuticals PLC Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Dr. Reddy?s Laboratories Ltd Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Grifols Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Nichi-Iko Group (Sagent) Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Teva Pharmaceutical Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Auromedics Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Sanofi Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Gland Pharma Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Endo International PLC Generic Injectable Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
